We observed that GPR119 expressed in human breast cancer cell lines and tumor tissues, and GPR119 agonists with gefitinib additively suppressed the growth of breast cancer cells and induced intrinsic apoptosis. The gene discussed is GPR119; the disease is breast carcinoma.